Effects of nitric oxide inhalation on pulmonary serial vascular resistances in ARDS

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 5, 1996, Pages 1375-1381

  Rossetti, Max ^a   Guénard, Hervé ^b   Gabinski, Claude ^b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CAPILLARY PRESSURE; LUNG EDEMA; LUNG VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL;

EID: 0029846711     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.5.8912751     Document Type: Article

References (36)

1. Rossaint, R., K. J. Falke, F. Lopez, K. Slama, U. Pison, and W. M. Zapol. 1993. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 328:399-405.
2. Zapol, W. M., M. T. Snider, M. A. Rie, M. Frikker, and D. A. Quinn. 1985. Pulmonary circulation during adult respiratory distress syndrome. In W. M. Zapol and K. J. Falke, editors. Acute Respiratory Failure, Vol. 24. Lung Biology in Health and Disease. Marcel Dekker, New York. 241-273.
3. Radermacher, P., Y. Huet, and F. Pluskwa. 1988. Comparison of ketanserin and sodium nitroprusside in patients with severe ARDS. Anesthesiology. 68:152-157.
4. Frostell, C. G., M. D. Fratacci, J. C. Wain, R. Jones, and W. M. Zapol. 1991. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83:2038-2047.
5. Frostell, C. G., H. Elomovist, G. Hendenstierna, J. Lundberg, and W. M. Zapol. 1993. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilatation. Anesthesiology 78:427-435.
6. Adnot, S., C. Kouyoumdjian, C. Defouilloy, P. Andrivet, S. Sediam, R. Herigault, and M. D. Fratacci. 1993. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am. Rev. Respir. Dis. 148:310-316.
7. Pepke-Zaba, J., T. W. Higenbottam, A. T. Dinh-Xuan, D. Stone, and J. Wallwork. 1991. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 338:1173-1174.
8. Roberts, J. D., D. M. Polaner, P. Lang, and W. M. Zapol. 1992. Inhaled nitric oxide in persistent pulmonary hypertension in the newborn. Lancet 340:818-819.
9. Gaston, B., J. M. Drazen, J. Loscalzo, and J. S. Stamler. 1993. The biology of nitrogen oxides in the airways. Am. Rev. Respir. Dis. 149: 538-551.
10. Cremona, G., M. Takao, and T. Higgenbottam. 1993. Identification of site of action of nitric oxide in isolated pig lungs by occlusion technique (abstract). Am. Rev. Respir. Dis. 147:A224.
11. Lindeborg, D. M., B. P. Kavanagh, K. Van Meurs, and R. G. Pearl. 1995. Inhaled nitric oxide does not alter the longitudinal distribution of pulmonary vascular resistances. J. Appl. Physiol. 78:341-348.
12. Rinaldo, J. E., and R. M. Rogers. 1982. Adult respiratory distress syndrome. Changing concepts of lung injury and repair. N. Engl. J. Med. 309:900-909.
13. Murray, J. F., M. A. Matthay, J. M. Luce, and M. R. Flick. 1988. An expanded definition of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 138:720-723.
14. Le Gall, J. R., P. Loirat, A. Alperovitch, P. Glaser, C. Granthil, D. Mathieu, P. Mercier, R. Thomas, and D. Villier. 1984. A simplified acute physiologic score for ICU patients. Crit. Care Med. 12:975-977.
15. Dawson, C. A., T. A. Bronikowski, J. H. Linehan, S. T. Haworth, and D. A. Rickaby. 1989. On the estimation of pulmonary capillary pressure from arterial occlusion. Am. Rev. Respir. Dis. 140:1228-1236.
16. Baconnier, P. F., A. Eberhard, and F. A. Grimbert. 1992. Theoretical analysis of occlusion techniques for measuring pulmonary capillary pressure. J. Appl. Physiol. 73:1351-1359.
17. Collee, C. G., K. E. Lynch, R. D. Hill, and W. M. Zapol. 1987. Bedside measurement of pulmonary capillary pressure in patients with acute respiratory failure. Anesthesiology 66:614-620.
18. Royer, F., D. Anglade, J. C. Peyrin, P. Gelas, and F. A. Grimbert. 1986. Estimation of effective pulmonary capillary pressure (EPCP) in intensive care patients. Bull. Eur. Physiopathol. Respir. 22:92S.
19. Grimbert, F. A. 1988. Effective pulmonary capillary pressure. Eur. Respir. J. 1:297-301.
20. Linehan, J. H., C. A. Dawson, and D. A. Rickaby. 1982. Distribution of vascular resistance and compliance in a dog lung lobe. J. Appl. Physiol. 53:158-168.
21. Townsley, M. I., R. J. Korthius, B. Rippe, G. C. Parker, and A. E. Taylor. 1986. Validation of double vascular occlusion method for Pc,i in lung and skeletal muscle. J. Appl. Physiol. 61:127-132.
22. Rippe, B., J. C. Parker, M. I. Townsley, N. A. Mortillaro, and A. E. Taylor. 1987. Segmental vascular resistances and compliances in dog lungs. J. Appl. Physiol. 62:1206-1215.
23. Allison, R. C., B. Rippe, R. V. Prasard, J. C. Parker, and A. E. Taylor. 1989. Pulmonary vascular permeability and resistance measurements in control and ANTU-injured dog lungs. Am. J. Physiol. 256: H1711-H1718.
24. Gaar, K. A., Jr., A. E. Taylor, L. J. Owens, and A. C. Guyton. 1967. Pulmonary capillary pressure and filtration coefficient in isolated perfused lung. Am. J. Physiol. 213:H910-H914.
25. Hakim, T. S., J. M. I. Maarek, and H. K. Chang. 1989. Estimation of pulmonary capillary pressure in intact dog lung using the arterial occlusion technique. Am. Rev. Respir. Dis. 140:217-224.
26. Siegel, L. C., and R. G. Pearl. 1988. Measurement of the longitudinal distribution of pulmonary vascular resistances from pulmonary artery occlusion pressure profiles. Anesthesiology 68:305-307.
27. Grimbert, F. A., P. Amardeil, H. Ettinger, J. C. Peyrin, and P. Girardet. 1994. Methodological assessment of pulmonary capillary pressure (Pcp) in intensive care patients (abstract). Am. J. Respir. Crit. Care Med. 149:A435.
28. Gabel, J. C., and R. E. Drake. 1978. Pulmonary capillary pressure in intact dog lungs. Am. J. Physiol. 235:H569-H573.
29. Dawson, C. A., J. H. Linehan, and T. A. Bronikowski. 1989. Pressure and flow in the pulmonary bed. In K. E. Weir and T. J. Reeves, editors. Pulmonary Vascular Physiology and Pathophysiology. Marcel Dekker, New York. 51-105.
30. Hakim, T. S., and S. Kelly. 1989. Occlusion pressures versus micropipette pressures in the pulmonary circulation. J. Appl. Physiol. 67:1277-1285.
31. Staub, C. N., H. Nagano, and M. L. Pearce. 1967. Pulmonary edema in dogs, especially the sequence of fluid accumulation in lungs. J. Appl. Physiol. 22:227-240.
32. Schuster, D. P. 1994. ARDS: clinical lessons from the oleic acid model of acute lung injury. Am. J. Respir. Crit. Care Med. 149:245-260.
33. De Mey, J. G., and P. M. Vanhoutte. 1982. Heterogenous behavior of canine arterial and venous wall. Importance of the endothelium. Circ. Res. 51:439-447.
34. Ignarro, L. J., R. E. Byrns, G. M. Berga, and K. S. Wood. 1987. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacological and chemical properties identical to those of nitric oxide radical. Circ. Res. 61:866-879.
35. Zhao, W., and H. Guenard. 1995. Effect of nitric oxide on in vitro responsiveness of bovine bronchus and pulmonary vessels. Eur. Respir. J. 8:755.
36. Mitchell, J. P., D. Schuller, F. S. Calandrino, and D. P. Schuster. 1992. Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am. Rev. Respir. Dis. 145:990-998.